Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 3/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13579467 | 1.00 | FPR2 (0.33) | FPR2KDM1A | |
| SCHEMBL13579491 | 0.99 | FPR2 (0.32) | FPR2KDM1A | |
| SCHEMBL13579351 | 0.94 | GABRA1 (0.36) | FPR2 | |
| SCHEMBL13579474 | 0.94 | GABRA1 (0.36) | FPR2 | |
| SCHEMBL13579495 | 0.93 | GABRA1 (0.35) | FPR2 | |
| SCHEMBL13579371 | 0.91 | FPR2 (0.34) | FPR2KDM1A | |
| SCHEMBL13579521 | 0.91 | FPR2 (0.34) | FPR2KDM1A | |
| SCHEMBL13579469 | 0.89 | FPR2 (0.32) | FPR2KDM1A | |
| SCHEMBL13579348 | 0.89 | FPR2 (0.32) | FPR2KDM1A | |
| SCHEMBL13579349 | 0.88 | FPR2 (0.31) | FPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372306-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2013-02-12 | — | — | US | disclosed |
| US-8372306-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2013-02-12 | — | — | US | disclosed |
| US-20090324854-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090324854-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090324854-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CTNND1, YWHAZ, OCIAD2 | FPR2 2669/4885KDM1A 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.